The Trump administration’s cuts to climate research and weather forecasting are “blinding” the U.S. to oncoming threats to ...

The FDA has launched a review of clinical trials involving the export of US patients’ living cells to China and other ...

From AI-powered inspections to bold regulatory shifts on dyes and sugar, the FDA has made waves in 2025. Here are the 17 most ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

US FDA halts new clinical trials that export Americans’ cells to foreign labs in hostile countries for genetic engineering: Maryland Friday, June 20, 2025, 09:00 Hrs [IST] The U ...

The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ ...

Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...

Hackers infiltrated one grocery distributor, and within days, there were bare shelves at stores around the country and even some pharmacies unable to fill prescriptions. That’s not the beginning of ...

Explore how food sensors are enhancing safety and transparency across the supply chain—and why regulatory approvals are ...

The order comes as the Trump administration vows to bring transparency back to the United States' health industry.

The initiative, referred to as the Commissioner’s National Priority Voucher program, allows drug developers to participate in a novel FDA priority program. The program significantly shortens the FDA ...

Healthcare executives involved with medical device purchasing identify their top cybersecurty threats and needs when vetting ...